Overview

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

Status:
Completed
Trial end date:
2014-03-04
Target enrollment:
Participant gender:
Summary
The study will estimate the preference of rheumatoid arthritis (RA) and Plaque Psoriasis (PsO) patients who self inject etanercept for one of two experimental autoinjectors.
Phase:
Phase 4
Details
Lead Sponsor:
Amgen
Treatments:
Etanercept